These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33010809)

  • 1. Completion of clinical trials in light of COVID-19.
    Burki TK
    Lancet Respir Med; 2020 Dec; 8(12):1178-1180. PubMed ID: 33010809
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fight against COVID-19: market overview and pipeline of ongoing trials].
    Pontremoli R; Richard G; Vuddamalay G; Groux N
    Med Sci (Paris); 2020 Dec; 36(12):1225-1232. PubMed ID: 33211647
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and readjusting clinical trials.
    van Dorn A
    Lancet; 2020 Aug; 396(10250):523-524. PubMed ID: 32828180
    [No Abstract]   [Full Text] [Related]  

  • 4. The evolution of clinical trials in response to COVID-19.
    Sarah A; Dean O; Berk M
    Med J Aust; 2021 Apr; 214(7):332-332.e1. PubMed ID: 33749864
    [No Abstract]   [Full Text] [Related]  

  • 5. Balancing clinical evidence in the context of a pandemic.
    Adashek JJ; Kurzrock R
    Nat Biotechnol; 2021 Mar; 39(3):270-274. PubMed ID: 33547424
    [No Abstract]   [Full Text] [Related]  

  • 6. Modifications to Communities for Healthy Living trial design resulting from COVID-19.
    Davison KK; Haneuse S
    Contemp Clin Trials; 2020 Dec; 99():106205. PubMed ID: 33152514
    [No Abstract]   [Full Text] [Related]  

  • 7. [The COVID-19 pandemic].
    Bessis S
    Med Mal Infect; 2020 Sep; 50(8S):8S20-8S24. PubMed ID: 33357972
    [No Abstract]   [Full Text] [Related]  

  • 8. Research during the SARS-CoV-2 pandemic.
    Muñoz de Nova JL; Ortega-Gómez M; Abad-Santos F;
    Med Clin (Barc); 2021 Jan; 156(1):39-40. PubMed ID: 33268132
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized  Controlled Trials Versus Real-World Data in the COVID-19 Era: A False Narrative.
    Lyman GH; Kuderer NM
    Cancer Invest; 2020 Nov; 38(10):537-542. PubMed ID: 33090883
    [No Abstract]   [Full Text] [Related]  

  • 10. Conducting Clinical Trials in the Time of a Pandemic.
    Beane JD; Dedhia PH; Ejaz A; Contreras CM; Cloyd JM; Tsung A; Pawlik TM
    Ann Surg; 2020 Sep; 272(3):e219-e221. PubMed ID: 32520739
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials for COVID-19 should include sex as a variable.
    Bischof E; Wolfe J; Klein SL
    J Clin Invest; 2020 Jul; 130(7):3350-3352. PubMed ID: 32392184
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of the lack of a unified research project framework: an investigation into the registration of clinical trials of COVID-19.
    Wang B; Lai J; Yan X; Jin F; Yao C
    Curr Med Res Opin; 2020 Jul; 36(7):1131-1135. PubMed ID: 32427000
    [No Abstract]   [Full Text] [Related]  

  • 13. Navigating Nonessential Research Trials During COVID-19: The Push We Needed for Using Digital Technology to Increase Access for Rural Participants?
    Noonan D; Simmons LA
    J Rural Health; 2021 Jan; 37(1):185-187. PubMed ID: 32282959
    [No Abstract]   [Full Text] [Related]  

  • 14. Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19.
    Sher T; Wright RS
    Mayo Clin Proc; 2020 Jun; 95(6):1130-1131. PubMed ID: 32376104
    [No Abstract]   [Full Text] [Related]  

  • 15. A Call for Pediatric COVID-19 Clinical Trials.
    Campbell JI; Ocwieja KE; Nakamura MM
    Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32398330
    [No Abstract]   [Full Text] [Related]  

  • 16. The coronavirus outbreak could make it quicker and easier to trial drugs.
    Ledford H
    Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
    [No Abstract]   [Full Text] [Related]  

  • 17. The COVID-19 pandemic and a reflection on the conduct of clinical trials in times of war.
    Pacheco RL; Cabrera Martimbianco AL; Riera R
    J Clin Epidemiol; 2021 Apr; 132():131-132. PubMed ID: 33301908
    [No Abstract]   [Full Text] [Related]  

  • 18. Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak.
    Viale G; Licata L; Sica L; Zambelli S; Zucchinelli P; Rognone A; Aldrighetti D; Di Micco R; Zuber V; Pasetti M; Di Muzio N; Rodighiero M; Panizza P; Sassi I; Petrella G; Cascinu S; Gentilini OD; Bianchini G
    Oncologist; 2020 Jul; 25(7):e1013-e1020. PubMed ID: 32412693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trials during pandemic crisis: How to ensure safety and maintain access to innovation].
    Vignot S; Le Blaye O; Fluckiger L; Errard S; Marin B; Chapel E
    Bull Cancer; 2020 Jun; 107(6):617-619. PubMed ID: 32414537
    [No Abstract]   [Full Text] [Related]  

  • 20. Conducting clinical trials during the COVID-19 pandemic.
    Collier EK; Hsiao JL; Shi VY
    J Dermatolog Treat; 2020 Jun; 31(4):330-332. PubMed ID: 32343162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.